Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 17, 2026
TickeronGET DAILY SIGNALS
SQM Stock: Analyst Targets Center on $80 With +55% Upside Potential

SQM Stock: Analyst Targets Center on $80 With +55% Upside Potential

Key Takeaways

  • The central $80 stock price target is the arithmetic mean of roughly 18 current analyst 12-month price targets (about $78.50, reported via S&P Global), rounded to a clean level.
  • The latest verified price is about $51.66, meaning a move to $80 requires roughly 55% upside — a substantial move, not a marginal one.
  • The analyst range is unusually wide, from about $44 to $110, reflecting sharp disagreement over the outlook for lithium pricing and the company's Chilean lithium partnership.
  • Key supports include record lithium sales volumes, a return to profitability, strong iodine and specialty plant nutrition results, and the Mt Holland expansion in Australia.
  • The biggest risks are lithium price volatility and oversupply, the dilutive Codelco joint venture, rising capital spending and state "take," and valuation concerns.
  • For more detail, review the ticker's Major News, Today's Price Move, Forecast, and Earnings pages, and explore Trending AI Robots for additional insight.

Analyst Price Targets and Consensus View

Sociedad Química y Minera de Chile S.A. (SQM) is a Chilean lithium and specialty chemicals producer, best known for lithium carbonate and hydroxide used in electric-vehicle batteries, alongside iodine and specialty plant nutrients. Its analyst coverage is broad but deeply divided. Based on roughly 18 analyst price targets, the average analyst price target stands near $78.50, which rounds to the $80 central target used here. The low-to-high range spans roughly $44 to $110, one of the widest spreads in the materials sector. The consensus rating is effectively a "Hold," with a near-even split between buy, hold, and a small sell contingent.

Bullish voices sit near the top of the range — Deutsche Bank, Scotiabank, and BMO Capital have carried targets at or near $100 at various points during 2026 — arguing that firmer lithium pricing and record volumes justify higher earnings power. More cautious firms, including Bank of America (Sell, around $58), Goldman Sachs (Hold, around $64), and Berenberg (Hold, around $66), warn that current valuation already discounts a recovery and that the Codelco joint venture structurally reduces SQM's share of future Chilean lithium earnings. JPMorgan moved to Neutral near $100 in mid-2026 after a strong rally, signaling that even optimistic analysts see limited near-term upside from elevated levels. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

With shares trading around $51.66, reaching $80 implies roughly 55% upside — a substantial move that would require both improved fundamentals and sustained investor conviction. SQM's 52-week range of roughly $50.89 to $98.00 underscores how volatile the name has been, and it also shows that the stock has traded above $80 within the past year. The path to $80 is plausible but not assured. The company returned to profitability in 2025 and reported record lithium sales volumes (above 84,000 metric tons of lithium carbonate equivalent in a single quarter) and record iodine prices during the first half of 2026. Second-quarter 2026 revenue more than doubled year over year. Yet the trailing P/E (price-to-earnings) ratio near 10–11x and a roughly 4.7% dividend yield reflect a market that is pricing in cyclical lithium risk rather than clean secular growth. A re-rating would likely require lithium prices to hold and volume growth to continue compounding.

What Could Support a Move Toward the Target

  • Record lithium volumes: demand from electric vehicles and battery energy storage has pushed quarterly sales volumes to all-time highs.
  • Recovering profitability: 2025 marked a swing from a prior-year loss to positive net income, with Q2 2026 EPS (earnings per share) of roughly $2.31.
  • Diversification: iodine and specialty plant nutrition provide earnings that are less correlated with lithium prices.
  • Growth projects: the approved Mt Holland expansion in Australia, with partner Wesfarmers, aims to double spodumene concentrate output and lower unit costs.
  • Analyst revisions: a cluster of target increases into 2026 signals improving, if not unanimous, sentiment.

What Could Prevent the Target From Being Reached

  • Lithium oversupply: Chinese inventory dynamics and new global supply could cap lithium carbonate prices near recent levels.
  • Codelco joint venture: the Nova Andino Litio partnership with Chile's state-owned Codelco reduces SQM's ownership of its core Chilean lithium assets, structurally capping EPS growth.
  • Rising state take and capex: higher taxes/royalties and heavy capital spending could pressure free cash flow and returns.
  • Valuation: if lithium prices soften, the market may compress the multiple even as volumes grow.
  • Technical resistance: prior highs near $98–$100 remain far above current levels, and a sustained breakout would require broad sector participation.

Technical Levels and Market Structure

SQM is trading near the lower end of its 52-week range, with immediate support in the $50.89–$53 zone and psychological support at $50. To the upside, the first meaningful resistance sits near the $65–$70 area, with more durable overhead supply around the prior $98–$100 highs. The long-term structure remains constructive only if the stock can hold above its recent lows while reclaiming the $65 level. From what I see, monitoring these levels closely helps clarify whether momentum is building.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms differ. Investors should watch quarterly lithium carbonate and hydroxide pricing, sales-volume guidance, the structure and terms of the Codelco joint venture, progress at Mt Holland, and iodine and plant-nutrition pricing. The next earnings release and subsequent guidance, along with any changes to analyst ratings and targets, are the most direct catalysts for whether the $80 objective comes into view. I’m watching this closely as the lithium cycle evolves.

AI Daily Buy/Sell Signals

In my own research process, Tickeron's AI Daily Buy/Sell Signals have become a useful layer for tracking names like this. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single static opinion, the system flags shifting momentum and trend changes as they develop. Traders and investors can use these signals to discover opportunities, monitor existing positions, and spot evolving trends more efficiently. For those tracking SQM's volatility, a systematic signal layer can help separate noise from genuine directional change.

Final Assessment

The $80 central target reflects the average of current analyst price targets — roughly $78.50 — not a guarantee, and the $44-to-$110 range shows how divided the Street remains. A move to $80 would require about 55% appreciation, driven by durable lithium pricing, continued record volumes, and progress on growth projects. The principal obstacles are lithium oversupply, the dilutive Codelco partnership, rising costs and state take, and valuation risk. SQM has traded above $80 within the past year, so the level is not hypothetical — but whether it returns there depends on the lithium cycle and execution rather than any single forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SQM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SQM in -5.12% downward trend, falling for three consecutive days on November 16, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SQM declined for three days, in 253 of 320 cases, the price declined further within the following month. The odds of a continued downward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SQM as a result. In 57 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for SQM turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 36 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

The Aroon Indicator for SQM entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SQM's RSI Oscillator exited the oversold zone, 18 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

SQM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.603) is normal, around the industry mean (2.284). P/E Ratio (11.838) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.300) is also within normal values, averaging (1.548). Dividend Yield (0.075) settles around the average of (0.039) among similar stocks. P/S Ratio (2.917) is also within normal values, averaging (48.960).

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. SQM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SQM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.6B. The market cap for tickers in the group ranges from 50 to 237.52B. LIN holds the highest valuation in this group at 237.52B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -8%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was -16%. GEVO experienced the highest price growth at 18%, while AMTX experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 50
Price Growth Rating: 58
SMR Rating: 78
Profit Risk Rating: 84
Seasonality Score: -2 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of potassium nitrate and iodine chemicals

Industry ChemicalsSpecialty

Industry
Chemicals Agricultural
Address
El Trovador 4285, 6th Floor
Phone
+56 224252000
Employees
7258
Web
https://www.sqm.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.